Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx
February 1, 2019Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma
In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …
Top Ten most popular articles on Pharmafile.com this week!
February 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10
Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …
Health officials declare state of emergency in Washington after 36 confirmed cases of measles
February 1, 2019Medical Communications MMR, Seattle, measles, oregon, portland, vaccines, washington
Health officials have declared a state of emergency in Washington as an outbreak of measles continues to spread. As January …
Novartis’ CAR-T therapy Kymriah gets NICE green light in diffuse large B-cell lymphoma
February 1, 2019Medical Communications, Sales and Marketing CAR-T, Cancer, Kymriah, NICE, Novartis, lymphoma, pharma
NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …
400 Pfizer employees set to strike over pensions
February 1, 2019Medical Communications EU, Ireland, Little Island, Pfizer, Ringaskiddy, SITPU, strike
400 Pfizer employees are set to go on strike in Ireland over an ongoing pensions dispute. Members of SITPU, Ireland’s …
Repurposed drugs: The Supreme Court deals a blow to patentees
January 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma
Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …
Stripper-turned-Insys sales rep gave lap dance to persuade doctor to prescribe fentanyl
January 31, 2019Medical Communications Sunrise Lee, US, chicago, corruption, insys, sales
A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …
Janssen’s Erleada meets primary endpoints in ongoing trial into metastatic castration-sensitive prostate cancer
January 31, 2019Research and Development Cancer, Erleada, Janssen, pharma, prostate cancer
Janssen has revealed that its androgen receptor (AR) inhibitor Erleada (apalutamide), in combination with androgen deprivation therapy (ADT), has been …
Mylan’s Wixela becomes first FDA-approved generic version of GSK’s Advair inhaler
January 31, 2019Sales and Marketing Advair, COPD, FDA, Wixela, asthma, generic, pharma
Mylan’s Wixela has become the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler to …
Purdue Pharma sought to expand into opioid addiction treatments while using McKinsey to counter “emotional messages”
January 31, 2019Business Services, Medical Communications Massachusetts, OxyContin, Purdue Pharma, US, USA, opioids
OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …
Health Secretary pledges to end transmission of HIV in England by 2030
January 31, 2019Medical Communications, Research and Development 2030, AIDS, England, HIV, UN, health
Through better prevention, detection and treatment, Health Secretary Matt Hancock has pledged to end transmission of HIV in England by …
Richard Ridinger resigns from CEO position at Lonza causing shares to plummet
January 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland
Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …
Read Pharmafocus January/February 2019 edition online now!
January 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines
We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …
Takeda’s dengue vaccine proves efficacious in massive Phase 3 trial
January 30, 2019Research and Development Dengue fever, TAK-003, Takeda, Vaccine, dengue, health, infectious diseases
Takeda’s dengue vaccine candidate TAK-003, has proved efficacious in preventing dengue fever in healthy children and adolescents in an ongoing …
Israeli biotech claims it has developed cure for cancer
January 30, 2019Research and Development Cancer, MuTaTo, biotech, israel, lung cancer, oncology
An Israeli biotech has claimed that it has developed a complete cure for cancer. Speaking to the Jerusalem Post, Dan …
Roche pulls plug on Alzheimer’s drug after Phase 3 failure
January 30, 2019Research and Development AC Immune, Alzheimer's, Roche, crenezumab, pharma
Roche has announced that it is to terminate two Phase 3 studies investigating the efficacy of its anti-beta-amyloid molecule crenezumab …
ABPI warns of skills shortage in UK caused by lack of STEM grads and Brexit
January 30, 2019Research and Development ABPI, UK, eomployment, skills, stem, work
The UK is falling behind Europe and the rest of the world in regards to the number of students studying …
Opioid drugmaker Purdue Pharma inks deal with Alivio over non-opioid inflammation drug
January 29, 2019Manufacturing and Production Alivio, Purdue Pharma, health, inflammation, opioids
Opioid drugmaker Purdue Pharma has entered into an agreement with inflammatory disease specialist Alivio Therapeutics for the development of the …
Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia
January 29, 2019Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma
It’s big news for Janssen and AbbVie as it emerged that their jointly-developed Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) …
Precision cancer treatment for dogs moves towards human testing
January 29, 2019Manufacturing and Production CAR-T therapy, Cancer, Precision Medicine, car t therapy, dogs, t cells, t-cells
Scientists at the University of Missouri have developed a patient specific, precision medicine treatment for bone cancer in dogs. The …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
